# A Study to Test Different Doses of BI 1569912 in People With Depression

> **NCT06558344** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 224 (actual)

## Conditions studied

- Depressive Disorder, Major

## Interventions

- **DRUG:** BI 1569912
- **DRUG:** Placebo matching BI 1569912

## Key facts

- **NCT ID:** NCT06558344
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-01
- **Primary completion:** 2025-05-02
- **Final completion:** 2025-05-12
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2025-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06558344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06558344, "A Study to Test Different Doses of BI 1569912 in People With Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06558344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*